SCHEMBL8628385

SCHEMBL8628385

c1cc2[nH]c(CC3CCCCC3)nc2cn1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.59
IDO1 P14902 2/20 0.46
KDM4C Q9H3R0 3/20 0.45
PDE9A O76083 3/20 0.44
LMNA P02545 1/20 0.41
HTR3A P46098 1/20 0.41
HRH4 Q9H3N8 1/20 0.41
TSHR P16473 1/20 0.40
RECQL P46063 1/20 0.40
UTS2R Q9UKP6 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
AOC1 P19801 1/20 0.38
AOC3 Q16853 1/20 0.38
CACNA1H O95180 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8628390 0.88 AAK1 (0.63) AAK1IDO1KDM4CPDE9ALMNA
SCHEMBL6759257 0.80 IDO1 (0.68) AAK1IDO1LMNAHRH4GRIN1
SCHEMBL17493802 0.79 AAK1 (0.79) AAK1IDO1TSHRRECQLCACNA1H
SCHEMBL4111972 0.78 IDO1 (0.70) AAK1IDO1LMNAHRH4GRIN1
SCHEMBL25318311 0.77 CYP1A2 (0.56) KDM4CLMNARECQL
SCHEMBL17494047 0.77 AAK1 (0.81) AAK1IDO1TSHRRECQLCACNA1H
SCHEMBL9534906 0.77 GRIN2B (0.64) IDO1GRIN1GRIN2B
SCHEMBL25319558 0.75 CYP1A2 (0.54) KDM4CRECQL
SCHEMBL8809271 0.75 AAK1 (0.51) AAK1IDO1LMNACACNA1H
SCHEMBL21034524 0.75 AAK1 (0.51) AAK1IDO1LMNAGRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821675-A1 NOVEL HYDROXAMIC ACID AND AMINO-CARBOXYLATE COMPOUNDS AS METALLOPROTEASE AND TNF INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-02-04 EP disclosed
WO-1996033176-A1 NOVEL HYDROXAMIC ACID AND AMINO-CARBOXYLATE COMPOUNDS AS METALLOPROTEASE AND TNF INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-10-24 WO disclosed